Main station|Member Center|Save the desktop|Mobile browsing
Ordinary Member

Kang Le Pharmaceutical Company

All over the country

sell
  • There is no classification
contact
  • Contact:白经理
  • Phone:13581800668
search
 
link
  • There is no link yet
home > sell > Price of Gefitinib in India for sale in Tangshan 13581800668 Price of Iressa in India
Price of Gefitinib in India for sale in Tangshan 13581800668 Price of Iressa in India
products: Views:4Price of Gefitinib in India for sale in Tangshan 13581800668 Price of Iressa in India 
price: 1500.00元/盒
MOQ: 1 盒
Total supply: 10000 盒
Delivery date: Shipped within 1 days from the date of payment by the buyer
Valid until: Long-term validity
Last updated: 2016-11-07 17:12
 
Details

"Kangle Medicine Welcomes You"!
[Our company promises: Honesty, genuine products at reasonable prices, selling conscientious medicines, cash on delivery]
Beijing Kangle Pharmaceutical
Selling Indian Iressa for sale, Indian Iressa price quotation, Beijing selling Indian Yiressa Ressa
Location: Beijing
Contact information qq
Contact person: Manager Bai
Business description
Sale of Indian Iressa Imported Indian Iressa Price Agency Indian Iressa Price of Iressa in India
Iressa for sale in India Gleevec in India
Functions and indications
This product is suitable for the treatment of locally advanced or metastatic non-small cell patients who have previously received chemotherapy. Lung cancer. Previous chemotherapy treatments mainly referred to platinum and docetaxel treatments.
The efficacy of patients with locally advanced or metastatic non-small cell lung cancer who have failed chemotherapy is established based on objective response rate indicators. There are no controlled studies showing improvement in disease-related symptoms and prolonged treatment. Clinical benefit in terms of survival. The existing data on the use of this product in the second-line treatment of non-small cell lung cancer are only based on uncontrolled clinical studies and need to be further confirmed by well-designed controlled clinical trials
For the first-line treatment of non-small cell lung cancer, the results of two large randomized controlled clinical trials showed that the platinum-based doublet chemotherapy regimen combined with this product did not show any benefit. Therefore, gefitinib does not show any benefit. suitable for this type of treatment.
Request for quotation
A total of0articles  Related Comments: